A Phase I Clinical Study of SHR-A2009 for Injection in Patients With Advanced Solid Tumors
Status:
Not yet recruiting
Trial end date:
2024-12-30
Target enrollment:
Participant gender:
Summary
This study is an open-label, multicenter Phase I clinical trial to evaluate the safety,
tolerability, pharmacokinetics and efficacy of SHR-A2009 for injection in patients with
advanced solid tumors.